Godavari Biorefineries, through its biotech arm Sathgen Therapeutics, has received a Chinese patent for its anti-cancer molecule HYDROXY-1, 4-NAPHTHALENEDIONE. The molecule has shown promising lab results in fighting breast and prostate cancer, marking a significant step in the company's biotech innovation efforts.